119 related articles for article (PubMed ID: 30079884)
1. Sulfonylurea receptor 1 expression is variable in adult and pediatric brain tumors.
Thompson EM; Halvorson K; McLendon R
Clin Neuropathol; 2018; 37(5):221-227. PubMed ID: 30079884
[TBL] [Abstract][Full Text] [Related]
2. Sulfonylurea Receptor 1 in Humans with Post-Traumatic Brain Contusions.
Martínez-Valverde T; Vidal-Jorge M; Martínez-Saez E; Castro L; Arikan F; Cordero E; Rădoi A; Poca MA; Simard JM; Sahuquillo J
J Neurotrauma; 2015 Oct; 32(19):1478-87. PubMed ID: 26398596
[TBL] [Abstract][Full Text] [Related]
3. Profile of intravenous glyburide for the prevention of cerebral edema following large hemispheric infarction: evidence to date.
King ZA; Sheth KN; Kimberly WT; Simard JM
Drug Des Devel Ther; 2018; 12():2539-2552. PubMed ID: 30147301
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of SUR1 decreases the vascular permeability of cerebral metastases.
Thompson EM; Pishko GL; Muldoon LL; Neuwelt EA
Neoplasia; 2013 May; 15(5):535-43. PubMed ID: 23633925
[TBL] [Abstract][Full Text] [Related]
5. Potential of glyburide to reduce intracerebral edema in brain metastases.
Boggs DH; Simard JM; Steven A; Mehta MP
Expert Rev Neurother; 2014 Apr; 14(4):379-88. PubMed ID: 24552576
[TBL] [Abstract][Full Text] [Related]
6. Sur1-Trpm4 Cation Channel Expression in Human Cerebral Infarcts.
Mehta RI; Tosun C; Ivanova S; Tsymbalyuk N; Famakin BM; Kwon MS; Castellani RJ; Gerzanich V; Simard JM
J Neuropathol Exp Neurol; 2015 Aug; 74(8):835-49. PubMed ID: 26172285
[TBL] [Abstract][Full Text] [Related]
7. Newly expressed SUR1-regulated NC(Ca-ATP) channel mediates cerebral edema after ischemic stroke.
Simard JM; Chen M; Tarasov KV; Bhatta S; Ivanova S; Melnitchenko L; Tsymbalyuk N; West GA; Gerzanich V
Nat Med; 2006 Apr; 12(4):433-40. PubMed ID: 16550187
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of the Sur1-Trpm4 channel reduces neuroinflammation and cognitive impairment in subarachnoid hemorrhage.
Tosun C; Kurland DB; Mehta R; Castellani RJ; deJong JL; Kwon MS; Woo SK; Gerzanich V; Simard JM
Stroke; 2013 Dec; 44(12):3522-8. PubMed ID: 24114458
[TBL] [Abstract][Full Text] [Related]
9. Glibenclamide for the treatment of ischemic and hemorrhagic stroke.
Caffes N; Kurland DB; Gerzanich V; Simard JM
Int J Mol Sci; 2015 Mar; 16(3):4973-84. PubMed ID: 25749474
[TBL] [Abstract][Full Text] [Related]
10. Resveratrol reduces cerebral edema through inhibition of de novo SUR1 expression induced after focal ischemia.
Alquisiras-Burgos I; Ortiz-Plata A; Franco-Pérez J; Millán A; Aguilera P
Exp Neurol; 2020 Aug; 330():113353. PubMed ID: 32380020
[TBL] [Abstract][Full Text] [Related]
11. SUR1-Associated Mechanisms Are Not Involved in Ischemic Optic Neuropathy 1 Day Post-Injury.
Nicholson JD; Guo Y; Bernstein SL
PLoS One; 2016; 11(8):e0148855. PubMed ID: 27560494
[TBL] [Abstract][Full Text] [Related]
12. Endothelial sulfonylurea receptor 1-regulated NC Ca-ATP channels mediate progressive hemorrhagic necrosis following spinal cord injury.
Simard JM; Tsymbalyuk O; Ivanov A; Ivanova S; Bhatta S; Geng Z; Woo SK; Gerzanich V
J Clin Invest; 2007 Aug; 117(8):2105-13. PubMed ID: 17657312
[TBL] [Abstract][Full Text] [Related]
13. Subarachnoid hemorrhage from brain tumors in childhood.
Yokota A; Kajiwara H; Matsuoka S; Kohchi M; Matsukado Y
Childs Nerv Syst; 1987; 3(2):65-9. PubMed ID: 3040248
[TBL] [Abstract][Full Text] [Related]
14. Pattern of recurrence in children with midline posterior fossa malignant neoplasms.
Wootton-Gorges SL; Foreman NK; Albano EA; Dertina DM; Nein PK; Shukert B; Cesario KB; Gage S; Rumack CM; Strain JD
Pediatr Radiol; 2000 Feb; 30(2):90-3. PubMed ID: 10663519
[TBL] [Abstract][Full Text] [Related]
15. Variants in genes encoding the SUR1-TRPM4 non-selective cation channel and sudden infant death syndrome (SIDS): potentially increased risk for cerebral edema.
Qu D; Schürmann P; Rothämel T; Dörk T; Klintschar M
Int J Legal Med; 2022 Jul; 136(4):1113-1120. PubMed ID: 35474489
[TBL] [Abstract][Full Text] [Related]
16. Silencing of Abcc8 or inhibition of newly upregulated Sur1-Trpm4 reduce inflammation and disease progression in experimental autoimmune encephalomyelitis.
Makar TK; Gerzanich V; Nimmagadda VK; Jain R; Lam K; Mubariz F; Trisler D; Ivanova S; Woo SK; Kwon MS; Bryan J; Bever CT; Simard JM
J Neuroinflammation; 2015 Nov; 12():210. PubMed ID: 26581714
[TBL] [Abstract][Full Text] [Related]
17. Emerging therapeutic targets for cerebral edema.
Jha RM; Raikwar SP; Mihaljevic S; Casabella AM; Catapano JS; Rani A; Desai S; Gerzanich V; Simard JM
Expert Opin Ther Targets; 2021 Nov; 25(11):917-938. PubMed ID: 34844502
[TBL] [Abstract][Full Text] [Related]
18. Role of Glibenclamide in Brain Injury After Intracerebral Hemorrhage.
Jiang B; Li L; Chen Q; Tao Y; Yang L; Zhang B; Zhang JH; Feng H; Chen Z; Tang J; Zhu G
Transl Stroke Res; 2017 Apr; 8(2):183-193. PubMed ID: 27807801
[TBL] [Abstract][Full Text] [Related]
19. SUR1-TRPM4 channel activation and phasic secretion of MMP-9 induced by tPA in brain endothelial cells.
Gerzanich V; Kwon MS; Woo SK; Ivanov A; Simard JM
PLoS One; 2018; 13(4):e0195526. PubMed ID: 29617457
[TBL] [Abstract][Full Text] [Related]
20. The epigenetics of brain tumors.
Dubuc AM; Mack S; Unterberger A; Northcott PA; Taylor MD
Methods Mol Biol; 2012; 863():139-53. PubMed ID: 22359291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
